Marcus Harrison Email and Phone Number
Marcus Harrison work email
- Valid
- Valid
- Valid
- Valid
Marcus Harrison personal email
A commercially focused leader with over 10 years’ experience in executive positions in the life science sector across private, listed, venture backed and not-for-profit organisations. Ability to think strategically, planning for growth, motivating teams, whilst also deploying skills and resources to support the day-to-day operations. A driven passionate leader with experience of building innovative teams in growth, established, start-up and turnaround environments leading delivery and change management, establishing collaborations and overseeing governance. In the current role played a pivotal part in shaping and growing the company from the ground-up into a high impact, multi-million revenue organisation, with a national reputation for supporting the drug discovery sector. In response to the onset of the COVID-19 pandemic played a leading role in establishing a diagnostic mega-lab, coordinating a broad team consisting of a range of government, academic and industry stakeholders.
-
Interim Chief Operating OfficerInfinitopesManchester, England, Gb -
Consultant And Fractional ExecutiveSelf-Employed Apr 2024 - PresentAdvisory and consultancy for innovation and life science organisations. - Novel drug discovery, biomarker and diagnostics platforms- Strategic, business and operational planning for spinouts and start-ups- Organisation and programme governance
-
Director Of Strategy Delivery And Partnerships, Usher InstituteThe University Of Edinburgh Oct 2022 - Mar 2024Edinburgh, GbThe Health and Social Care Data-Driven Innovation (HSCDDI) programme seeks to drive advances in health and social care through the application of data science through collaborations between academics, service providers and industry to identify, evaluate and adopt new solutions to improve health outcomes. • Provide senior strategic and operational leadership for the delivery of the Data-Driven Innovation initiative• Ownership, implementation and delivery of the objectives and key deliverables for the Talent; Research; Adoption; Data and Entrepreneurship (TRADE) business plans• Lead and coordinate the central delivery team• Oversee the fit-out, occupation and transition to the new Usher building• Develop strategic partnerships across a wide network of clinical, social care and commercial partners -
Chief Operating OfficerMedicines Discovery Catapult Apr 2017 - Jul 2022Alderley, Cheshire, GbMDC is a national facility for collaborative R&D exploring and developing new approaches to the discovery and proof of well targeted medicines, diagnostics and biomarkers. Strategic initiatives link the industry with national stakeholders to provide new foundation processes and collaborative projects with industry and academia lay stepping stones towards proven new techniques and technologies. MDC is an independent not-for-profit limited company bringing together a fragmented UK sector of industry, academia, charities, technologists, services, finance companies, SMEs and start-ups who together can turn good science into new, high value products. By sharing problems, rare expertise and assets we support the growth of this new community through a time of radical business and national change.• Responsibilities have included for Programme Management, Finance, Risk, Governance, Legal/IP, IT, HR, Procurement & Facilities• Strategic and operational planning• Building the operations team from the ground up• Established operations of the Lighthouse Laboratory that quickly went on to process 80,000 COVID-19 samples per day• Working with key stakeholders, funders and board members -
Fractional & Interim Chief Operating OfficerNalia Systems Limited Jun 2016 - Apr 2017Grenville Place Mill Hill, London, GbNALIA systems developed a multiplex point of care (POC) platform for the diagnosis of autoimmune and infectious diseases. • Coordinating technology platform developments• Supporting fund raising activities. -
Fractional & Interim Chief Executive OfficerCeryx Medical Ltd Mar 2016 - Apr 2017Cardiff, Wales, GbCeryx Medical is a bioelectronics spinout from the Universities of Bath and Bristol developing unique technologies for reinstating physiologically dynamic feedback controls to the heart. • Working with founding academics to define the commercial opportunities, clinical route to market and fund raising. -
Fractional & Interim Chief Operating OfficerGenefirst Ltd Feb 2016 - Oct 2016Abingdon, Oxfordshire, GbGeneFirst is a molecular diagnostics company working predominantly in the fields of infectious disease, cancer diagnostics and personalised medicine. The technology portfolio includes, highly multiplexed quantitative PCR assays (up to 20 assays per well) and tagged bi-directional next generation sequencing for detecting circulating tumour (ct) DNA.• Obtained regulatory approval (CE Marking) and transfer to manufacturing (ISO 13485) of the company's first product, Papilloplex, which enables the simultaneous detection and genotyping of 14 different high-risk Human Papillomavirus (HPV) strains in an easy-to-use single-closed tube. -
Chief Executive & Technology OfficerNanotether Discovery Sciences Ltd Aug 2012 - Dec 2015A Cardiff University spinout company developing a novel assay technology platform and applications for pre-clinical drug discovery research.• Responsible for the strategic and commercial direction, and technical delivery of the core technology platform. • Industrialised an academic biological assay platform and led business development activities to establish a network of key opinion leaders leading to initial national and international collaboration projects.• Led business development activities for the company’s first collaborations. • Undertaking fund raising activities and securing grant funding
-
Chief Scientific Officer (Board Director) & Director Of The Biomedical DivisionMediwatch Plc Jan 2009 - Jun 2012GbMediwatch Plc (acquired by Laborie in 2014) were designers, manufacturers and suppliers of high-technology urology products for the screening, diagnosis and assessment of a variety of clinical disorders. Mediwatch were a quality assured company and have received prestigious awards for both Innovation & Research. Mediwatch Biomedical Ltd was the In-Vitro Diagnostic (IVD) division of Mediwatch developing products for the point-of-care market. Mediwatch were acquired by Laborie in January 2014.• Coordinated programmes across the full product lifecycle, including feasibility testing, full development, performance enhancements, coordinating clinical trials (FDA 510k), obtaining regulatory approval (CE marking) and transferring to manufacturing partner (ISO 13485). • Undertook business development activities to build a pipeline of new products. • Oversaw commercialisation of flagship product, including working with key opinion leaders, presenting at conferences, coordinating training programs and meeting with distributors. • Developed a five year strategic plan for the Biomedical Division, including extension of current product range and route to identifying/in-licensing next generation platform and applications. -
Head Of ServicesOxford Gene Technology Jul 2007 - Dec 2008Kidlington, Oxfordshire, GbOGT focus on developing services and innovative products for the academic research and clinical diagnostics markets.Coordinated sales/marketing activities and project management delivering up to 30 projects simultaneously across molecular diagnostics, functional genomics, oncology and microbiology. -
Head Of Computational BiologyOxford Gene Technology Nov 2003 - Dec 2008Kidlington, Oxfordshire, GbEstablished the computational biology group developing core infrastructure, capabilities, informatics systems and software products. -
Head Of Technical ProgrammesOxford Gene Technology Sep 2005 - Jun 2007Kidlington, Oxfordshire, Gb -
Senior Bioinformatician (Acquired By Astrazeneca In 2007)Arrow Therapeutics Jan 2002 - Nov 2003GbSenior scientist within an inter-disciplinary discovery team identifying novel therapeutic and vaccine targets. -
Bioinformatician (Acquired By Arrow Therapeutics In January 2002)Oxford Gene Technology Feb 2000 - Jan 2002Kidlington, Oxfordshire, GbDeveloped analytical software and systems for designing DNA microarray probes, analysing large quantities of biological data and data workflows. -
BiophysicistQuadram Institute Oct 1994 - Feb 2000Norwich, Norfolk, GbPost-doctoral research which investigated the effect of the food matrix on flavour release and perception, leading to 20 peer reviewed publications and collaborations in Europe.
Marcus Harrison Skills
Marcus Harrison Education Details
-
The University Of SheffieldPhysics -
The University Of SheffieldTheoretical Physics
Frequently Asked Questions about Marcus Harrison
What company does Marcus Harrison work for?
Marcus Harrison works for Infinitopes
What is Marcus Harrison's role at the current company?
Marcus Harrison's current role is Interim Chief Operating Officer.
What is Marcus Harrison's email address?
Marcus Harrison's email address is ma****@****.org.uk
What schools did Marcus Harrison attend?
Marcus Harrison attended The University Of Sheffield, The University Of Sheffield.
What skills is Marcus Harrison known for?
Marcus Harrison has skills like Biotechnology, Molecular Biology, Life Sciences, Start Ups, Bioinformatics, R&d, Hardware Diagnostics, Lifesciences, Genomics, Assay Development, Project Management, Commercialization.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial